Cargando…
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Immunotherapies like the adoptive transfer of gene-engineered T cells and immune checkpoint inhibitors are novel therapeutic modalities for advanced cancers. However, some patients are refractory or resistant to these therapies, and the mechanisms underlying tumor immune resistance have not been ful...
Autores principales: | Tie, Yan, Tang, Fan, Wei, Yu-quan, Wei, Xia-wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118588/ https://www.ncbi.nlm.nih.gov/pubmed/35585567 http://dx.doi.org/10.1186/s13045-022-01282-8 |
Ejemplares similares
-
Surgical trauma‐induced immunosuppression in cancer: Recent advances and the potential therapies
por: Tang, Fan, et al.
Publicado: (2020) -
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
por: Li, Kai, et al.
Publicado: (2021) -
Cell Heterogeneity Uncovered by Single-Cell RNA Sequencing Offers Potential Therapeutic Targets for Ischemic Stroke
por: Qiu, Min, et al.
Publicado: (2022) -
Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
por: Ma, Jie, et al.
Publicado: (2018) -
The identification of neutrophils-mediated mechanisms and potential therapeutic targets for the management of sepsis-induced acute immunosuppression using bioinformatics
por: Chen, Fang, et al.
Publicado: (2021)